Literature DB >> 161910

Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin.

P M Schlievert, K M Bettin, D W Watson.   

Abstract

Because of the association of the group A streptococcal pyrogenic exotoxins (SPEs) with erythrogenic toxin used in the classical Dick test, the involvement of the SPEs in production of erythematous skin reactions was assessed. Unless they had been presensitized, young adult rabbits failed to show skin reactions after intracutaneous challenged with SPEs. Rabbits presensitized to purified protein derivative exhibited enhanced skin reactivity when given purified protein derivative plus SPE C; the enhancement was neutralized by antiserum to SPE C. Rabbits sensitized to bovine serum albumin showed extensive red rash development resembling scarlet fever rashes when given bovine serum albumin containing SPE C. Desquamation occurred 5 to 10 days after injection. Animals sensitized to one SPE type showed enhanced skin reactivity to challenge with homologous or heterologous SPE types, indicating the presence of a cross-reactive determinant within the SPE molecules. Repeated challenge of SPE-sensitized animals with homologous toxin resulted in concomitant antitoxin production with reduction of the enhanced skin reactivities, until typical delayed-hypersensitivity skin reactions remained. The data indicate that, in addition to the toxic reaction previously described, SPEs enhance Arthus and delayed-hypersensitivity skin reactions. It follows that erythrogenic toxin represents the enhancement of acquired skin reactivity to streptococcal antigens by one or more SPE types. Therefore, the Dick test measures SPE-enhanced hypersensitivity to streptococcal products.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 161910      PMCID: PMC414639          DOI: 10.1128/iai.26.2.467-472.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Further studies of group A streptococcal factors with lethal and cardiotoxic properties.

Authors:  J H SCHWAB; D W WATSON; W J CROMARTIE
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

2.  Alteration of clearance function by group A streptococcal pyrogenic exotoxin and its relation to suppression of the antibody response.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Purification and characterization of group A streptococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

4.  Enhanced immune response after immunosuppression by Streptococcal pyrogenic exotoxin.

Authors:  E E Hanna; D W Watson
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

5.  Deregulation of mouse antibody-forming cells by streptococcal pyrogenic exotoxin. II. Modification of spleen T-cell-complemented nude mouse PFC responses.

Authors:  M L Hale; E E Hanna
Journal:  Cell Immunol       Date:  1976-10       Impact factor: 4.868

6.  Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved.

Authors:  C M Cunningham; D W Watson
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

7.  Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock.

Authors:  P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins.

Authors:  E L Barsumian; P M Schlievert; D W Watson
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  HOST-PARASITE RELATIONSHIPS AMONG GROUP A STREPTOCOCCI. 3. DEPRESSION OF RETICULOENDOTHELIAL FUNCTION BY STREPTOCOCCAL PYROGENIC EXOTOXINS.

Authors:  E E HANNA; D W WATSON
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

10.  Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

Authors:  D W WATSON
Journal:  J Exp Med       Date:  1960-02-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988.

Authors:  A Bucher; P R Martin; E A Høiby; A Halstensen; A Odegaard; K B Hellum; L Westlie; S Hallan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci.

Authors:  C E Yu; J J Ferretti
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

3.  Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C.

Authors:  J Yamaoka; E Nakamura; Y Takeda; S Imamura; N Minato
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

4.  Fulminant group A streptococcal infections. Report of two cases.

Authors:  R D Christen; R Moser; P Schlup; K A Neftel
Journal:  Klin Wochenschr       Date:  1990-04-17

5.  Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness.

Authors:  P K Lee; P M Schlievert
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

6.  Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B.

Authors:  L P Johnson; J J L'Italien; P M Schlievert
Journal:  Mol Gen Genet       Date:  1986-05

7.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12.

Authors:  C R Weeks; J J Ferretti
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

Review 9.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

10.  Ganglioside and monosaccharide inhibition of nonspecific lymphocyte mitogenicity by group A streptococcal pyrogenic exotoxins.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.